We are in the midst of a significant shift in pharmaceutical drug development, with many leading companies focusing increasingly on orphan drugs targeted at small niche markets.
As part of pharmaphorum’s eye-on-innovation series of interviews, Richard Staines speaks to Michael Sierra, Vice President of LEO Pharma’s Science and Tech Hub, about how the firm plans to chan
The concept of evidence-based medicine (EBM), coined by Gordon Guyatt in 1992 to refer to the use of modern, best evidence in making decisions about the care of individual patients
The Information Commissioner has ruled that a major hospital failed to comply with the Data Protection Act when it provided patient details to Google’s DeepMind.
